Streetbeat News

Price Targets

MC

Goldman Sachs has reaffirmed its Sell rating on Moelis & Co (NYSE:MC) but increased its price target from $41.00 to $47.00. Despite the upgrade in the price target, the new target still suggests a potential downside of 17.25% from the current share price of $56.80. Moelis & Co is an independent investment bank offering strategic and financial advice globally, with the majority of its revenue coming from the United States.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

PRLD

Morgan Stanley has downgraded Prelude Therapeutics (NASDAQ:PRLD) from an unspecified rating to Underweight, slashing the price target from $10.00 to $4.00. Despite the downgrade, PRLD shares remained stable over the last 24 hours at $4.37. The new price target suggests a potential downside of 8.47% from the current share price. Prelude Therapeutics is a clinical-stage company developing therapies for cancers with high unmet need.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

LEGN

Legend Biotech (NASDAQ:LEGN) received 4 analyst ratings in the last quarter, with 2 bullish, 1 somewhat bullish, and 1 indifferent. The 12-month price targets from these analysts average $82.75, with a high of $93.00 and a low of $65.00. The current average shows a 5.61% decline from the prior average. Legend Biotech is a clinical-stage biopharmaceutical company with a lead CAR T cell therapy product for multiple myeloma. The company has shown a revenue growth rate of 250.91% as of September 30, 2023, but faces challenges with a net margin of -64.79%, ROE of -4.53%, and ROA of -3.3%. Its debt-to-equity ratio is 0.24, below industry norms.

Portfolio Pulse from Benzinga Insights

December 19, 2023 | 5:00 pm

BRKR

Wells Fargo analyst Timothy Daley has initiated coverage on Bruker Corporation with an Equal-Weight rating and set a price target of $72. The initiation of coverage is likely to influence investor perception and could impact the stock's performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:54 pm

NFE

Capital One analyst Wade Suki has initiated coverage on New Fortress Energy (NASDAQ:NFE) with an Equal-Weight rating and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:49 pm

ELAN

Jefferies analyst Glen Santangelo has initiated coverage on Elanco Animal Health (NYSE:ELAN) with a Buy rating and set a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:47 pm

ZTS

Jefferies analyst Glen Santangelo has initiated coverage on Zoetis (NYSE:ZTS) with a Buy rating and set a price target of $230.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:42 pm

PPSI

Lake Street analyst Robert Brown has initiated coverage on Pioneer Power Solutions (NASDAQ:PPSI) with a Buy rating and set a price target of $12.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:40 pm

ACLS

Arcellx, Inc. (ACLS) stock price has risen following Scotiabank's initiation of coverage with a Sector Outperform rating and a $66 price target.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:38 pm

HI

CL King analyst Tom Hayes has initiated coverage on Hillenbrand (NYSE:HI) with a Strong Buy rating and set a price target of $61.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 4:34 pm